Skip to main content
Google Tag Manager
P&T COMMUNITY
Register
Sign in
Search form
Search
News
Approvals, Launches, & New Indications
Pipeline Plus
Research News
Industry Trends
Safety Issues
Agency Actions
Health Care Reform
Guidelines
Clinical Trials
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Reports
Health Care & Law
Drug Forecast
More
Meeting Highlights
Medication Errors
Prescription: Washington
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
JAKAFI®
ruxolitinib (tablets)
PERSERIS™
(risperidone) for extended-release injectable suspension
ZULRESSO™
(brexanolone) injection CIV
You are here
Home
News by month %2 2016
News by month November 2016
PTCommunity News November 2016
Will Tighter Prescribing Rules Hurt Patients in Pain?
U.S. Blood-Collection System Faces Multiple Threats, Study Finds
Tardive Dyskinesia Drug Valbenazine Set for FDA Review
Herceptin Biosimilar Succeeds in Key Breast Cancer Trial
Experimental Device Heals Wounds With Low-Frequency Ultrasound
Trump Picks Obamacare Critic to Lead Health Care Overhaul
Deadly Infections Linked to Heart Surgery Device
Texas Reports First Local Case of Zika Virus Infection
FDA Expands Labeling for Leukemia Drug Iclusig
Skin Cancer Immunotherapy Avelumab Wins Priority Review
Potent Antibody Neutralizes Zika Infection in Early Research
Scientists Develop Infection-Detecting Bandages
21st Century Cures Act Sparks Lobbying Frenzy
Gallup Survey: Most Americans Want Changes to Affordable Care Act
FDA on Hot Seat for Clinical Trial Deaths
Lilly’s Solanezumab Fails in Phase 3 Alzheimer’s Trial
Patient Death Halts CAR T-Cell Immunotherapy Trial in Leukemia Again
Hypertension and Prehypertension Underdiagnosed, Undertreated in U.S. Children
Researchers Find Potential Therapy for Brain Swelling During Concussion
Benzodiazepines and Related Drugs Increase Hip Fracture Risk in Alzheimer’s Patients
Report Identifies Teaching Hospitals That Threaten Patient Safety
Study Examines Rates, Causes of ED Visits for Adverse Drug Events
Study: Babies Exposed to Zika Virus Developed Microcephaly After Birth
FDA Approves Darzalex With Two Standard-of-Care Regimens for Treatment of Multiple Myeloma
Combo Diabetes Treatment Soliqua Wins FDA Nod
Florida Keys Move Ahead With Trial of Self-Limiting, Gene-Modified Mosquitoes
Study Finds Key Protein That Binds to LDL Cholesterol
More Than 20 Million U.S. Children Lack Sufficient Access to Health Care
Application for Triple-Drug, Single-Inhaler COPD Treatment Submitted to FDA
Report: 18.2 Million People Worldwide Are on HIV Antiretroviral Therapy
Former Valeant and Philidor Executives Charged in Fraud and Kickback Scheme
Viagra Linked With Reduced Heart Attack Risk and Improved Heart Attack Survival
Menopausal Hormone Therapy Improves Bone Health
WHO Secures Global Health Funding for Malaria Vaccine
International Research Collaboration Creates Powerful New Tools to Combat Zika
Surgeon General Issues Landmark Report on Alcohol, Drugs, and Health
Erenumab Significantly Reduces Monthly Migraine Days in Phase 3 Trial
FDA Approves Intrarosa for Postmenopausal Women Experiencing Pain During Sex
BACE Inhibitor Receives FDA Fast-Track Designation for Early Alzheimer's Disease
Serious, Highly Drug-Resistant Infections Increasing Among U.S. Children
Avastin Biosimilar Submitted for FDA Review
Entresto Data Show Long-Term Benefits on Heart Failure Readmissions
First Head-to-Head Study of Cimzia and Humira in Bio-Naïve RA Patients
Photoimmunotherapy ‘Bursts’ Tumors, Spares Nearby Cells
Analysts: CMS Hospital Rankings Fail ‘Common Sense Test’
CDC Announces ‘Get Smart About Antibiotics Week’
New Medicare List of Most Expensive Drugs Shows Massive Price Hikes
Heart Risks of Celebrex ‘Dispelled,’ Drugmaker Says
FDA Approves Defibrillator That Automatically Adjusts Pacing
Cosentyx Improves Psoriatic Arthritis in Three-Year Study
Simple Changes to Antibiotic Treatment May Help Beat MRSA, Researchers Find
USPSTF Recommends Statin Use for Primary Prevention of Cardiovascular Disease in Some Adults
Midostaurin Granted Priority Review for AML
RA Treatment Sirukumab Shows Mixed Results Against Humira
FDA Says ‘No’ for Now to Hepatitis B Vaccine
Tiny Super Magnets Could Be Future of Drug Delivery
Multidrug-Resistant Infection Spreading Globally Among CF Patients
Vemlidy Wins FDA Nod as Hepatitis B Medication
FDA Expands Opdivo Indications to Include Head-and-Neck Cancer
New Combo Therapy Could Cure Hepatitis C in Four Weeks, Researchers Say
Donald Trump Issues Health Care Mission Statement
Report: Obamacare ‘Replacement’ Might Look Familiar
Study: Readmission Penalties Are Punishing Safety-Net Hospitals
Hospital System Creates $10 EpiKit to Compete With EpiPen
New Screening Test Identifies Potential Therapies to Fight Drug-Resistant Bacteria
HIV Antibody Therapy Ibalizumab Succeeds in Phase 3 Trial
Trump, GOP Could Use ‘Must-Pass’ Bills to Bring Health Care Changes
Report: CMS Knew About Misclassification of EpiPens Since 2009 But Did Nothing
Disgraced Theranos Hit With $140 Million Lawsuit
‘Zika Can Break Out Anywhere,’ Expert Warns
Scientists Develop Hand-Held 'Breathalyzer' to Diagnose Diabetes
Three Health Issues the Candidates Should Have Talked About––But Didn’t
Drug Price Hikes Are “Unsustainable,” Medicare Chief Says
Testing of Investigational Zika Vaccine Begins in Humans
FDA Puts Brakes on Multiple Myeloma Study
Laughing Gas for Labor Pain?
Valeant Pharma Sued Over Female Libido Pill
Medical Device Tax Becomes Campaign Fodder
FDA Approves Expanded Use of Enbrel in Children With Chronic Plaque Psoriasis
FDA Advisors Recommend Approval of Solithromycin in Narrow Vote
Bayer Submits FDA Application for Stivarga as Liver Cancer Treatment
Antitrust Probe Targets Generic Drug Makers
High Hospital Profits Hurt Medicine, Expert Says
Why Did FDA Approve Controversial Muscular Dystrophy Drug Exondys 51?
CDC Reports First Cases of Candida auris in United States
Report: Opdivo/Yervoy Combo May Threaten the Heart
FDA’s Drug Approval Team Copes With 700 Unfilled Jobs
MIT Study: Both Providers and Patients Drive Health Care Spending
HHS Adds Five Viruses to Report on Carcinogens
Blood Clots Dent Hopes for Hemophilia Drug Emicizumab
Verubecestat Shows Promise in Alzheimer’s Disease
Bremelanotide Shows Promise as On-Demand Treatment for Hypoactive Sexual Desire Disorder
How to Make Big Bucks Flipping Drugs
FDA Staff Cites Liver Safety Issues With Pneumonia Drug Solithromycin
Study: Common Costly Clot Test Has Few Benefits
Ovarian Cancer Drug Niraparib Submitted to FDA
Pfizer Dumps Cholesterol Drug Bococizumab
New Heart Failure Guidelines Emphasize Early Diagnosis and Treatment
